This article only represents the author's own views.
Money scandals, regulatory setbacks and a stock trading suspension. It’s been a challenging few years for China’s leading chain of private psychiatric hospitals, Wenzhou Kangning Hospital Co. Ltd. (2120.HK).
The company’s bid to join China’s A-shares market was blocked by regulators in 2018. And after another attempt to list on Shanghai’s Nasdaq-style STAR Market, the company was rocked by an accounting controversy that has halted trading in its shares since April last year.
您已阅读8%（531字），剩余92%（6087字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。